scholarly article | Q13442814 |
P50 | author | Dafna D. Gladman | Q37605821 |
P2093 | author name string | Murray B Urowitz | |
Zahi Touma | |||
Dominique Ibañez | |||
P2860 | cites work | Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus | Q28319260 |
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Premature atherosclerosis in systemic lupus erythematosus | Q33893354 | ||
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
The metabolic syndrome: prevalence, CHD risk, and treatment | Q36408039 | ||
Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. | Q37209371 | ||
Risk factors for development of coronary artery disease in women with systemic lupus erythematosus | Q37615743 | ||
Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus | Q38454380 | ||
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women | Q40192779 | ||
Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference | Q43281114 | ||
The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Nonfasting triglycerides and risk of ischemic stroke in the general population | Q44734713 | ||
Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction | Q46291367 | ||
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 | ||
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. | Q51680170 | ||
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. | Q51733116 | ||
SLEDAI-2K for a 30-day window. | Q51799721 | ||
Triglycerides and the Risk of Coronary Heart Disease | Q57267183 | ||
P433 | issue | 3 | |
P921 | main subject | coronary artery disease | Q844935 |
triglyceride | Q186319 | ||
P304 | page(s) | 528-534 | |
P577 | publication date | 2011-11-24 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. | |
P478 | volume | 51 |
Q35525108 | Atherosclerosis in systemic lupus erythematosus |
Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q37673404 | Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice |
Q51305109 | Deviant early pregnancy maternal triglyceride levels and increased risk of congenital anomalies: a prospective community-based cohort study. |
Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
Q39283399 | The evolving concept of SLE comorbidities. |
Search more.